Fanny Wunder
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 5
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Josep M. Tabernero (1 shared paper)Christophe Le Tourneau (1 shared paper)Gerald Batist (2 shared papers)Jacques Raynaud (3 shared papers)Vladimir Lazar (3 shared papers)Razelle Kurzrock (5 shared papers)Richard L. Schilsky (2 shared papers)Catherine Bresson (5 shared papers)
- Journals
- Therapeutic Advances in Medical Oncology (3 papers)Oncotarget (2 papers)Annals of Oncology (2 papers)Nature Medicine (1 paper)npj Precision Oncology (1 paper)
- Partner nations
- United StatesIsraelFrance
In The Last Decade
Fanny Wunder
10 papers receiving 479 citations
Fanny Wunder's Hit Papers
Peers
Comparison fields: 5 of 54
- Cancer Research 239
- Oncology 167
- Pulmonary and Respiratory Medicine 109
- Pathology and Forensic Medicine 43
- Otorhinolaryngology 10
Countries citing papers authored by Fanny Wunder
This map shows the geographic impact of Fanny Wunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Wunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Wunder more than expected).
Fields of papers citing papers by Fanny Wunder
This network shows the impact of papers produced by Fanny Wunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Wunder. The network helps show where Fanny Wunder may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanny Wunder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial Hit paper breakdown → | 2019 | 437 |
| 2 | 2022 | 19 | |
| 3 | 2023 | 11 | |
| 4 | 2021 | 8 | |
| 5 | 2022 | 7 | |
| 6 | 2019 | 4 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2014 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 0 |
About Fanny Wunder
Fanny Wunder is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Psychiatry and Mental health, having authored 11 papers that have together received 491 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Genetic factors in colorectal cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers), COVID-19 Clinical Research Studies (1 paper), Lung Cancer Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Bioinformatics and Genomic Networks (1 paper). The work is most often cited by research in Cancer Research (239 citations), Oncology (167 citations), Pulmonary and Respiratory Medicine (109 citations), Pathology and Forensic Medicine (43 citations) and Otorhinolaryngology (10 citations). Fanny Wunder has collaborated with scholars based in United States, Israel and France. Frequent co-authors include Josep M. Tabernero, Christophe Le Tourneau, Gerald Batist, Jacques Raynaud, Vladimir Lazar, Razelle Kurzrock, Richard L. Schilsky, Catherine Bresson, Michel Pierre Ducreux and Enriqueta Felip. Their work appears in journals such as Therapeutic Advances in Medical Oncology, Oncotarget, Annals of Oncology, Nature Medicine and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.